ZA964889B - A method for promoting enzyme diversity - Google Patents
A method for promoting enzyme diversityInfo
- Publication number
- ZA964889B ZA964889B ZA964889A ZA964889A ZA964889B ZA 964889 B ZA964889 B ZA 964889B ZA 964889 A ZA964889 A ZA 964889A ZA 964889 A ZA964889 A ZA 964889A ZA 964889 B ZA964889 B ZA 964889B
- Authority
- ZA
- South Africa
- Prior art keywords
- sequence
- enzyme
- antibody
- animal
- variable region
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/505,528 US5919681A (en) | 1995-06-07 | 1995-06-07 | Method for promoting enzyme diversity |
| US08/476,135 US5914256A (en) | 1995-06-07 | 1995-06-07 | Method for promoting enzyme diversity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA964889B true ZA964889B (en) | 1997-07-08 |
Family
ID=27045085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA964889A ZA964889B (en) | 1995-06-07 | 1996-06-07 | A method for promoting enzyme diversity |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5922584A (fr) |
| EP (2) | EP1437414A3 (fr) |
| JP (1) | JP4102435B2 (fr) |
| AT (1) | ATE274594T1 (fr) |
| AU (1) | AU719670B2 (fr) |
| CA (1) | CA2223716C (fr) |
| DE (1) | DE69633238T2 (fr) |
| DK (1) | DK0839208T3 (fr) |
| ES (1) | ES2227594T3 (fr) |
| WO (1) | WO1996040960A1 (fr) |
| ZA (1) | ZA964889B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1327682B1 (fr) * | 2002-01-11 | 2009-05-13 | BioSpring Gesellschaft für Biotechnologie mbH | Procédé de production de l'ADN |
| EP2825653A4 (fr) | 2012-03-14 | 2016-01-20 | Innovative Targeting Solutions Inc | Production d'une diversité de séquence ciblée dans des protéines de fusion |
| WO2013134880A1 (fr) * | 2012-03-14 | 2013-09-19 | Innovative Targeting Solutions Inc. | Production d'une diversité de séquence ciblée dans des protéines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5156965A (en) * | 1983-11-29 | 1992-10-20 | Igen, Inc. | Catalytic antibodies |
| US5037750A (en) * | 1984-11-27 | 1991-08-06 | Igen, Inc. | Method for producing antibodies which catalyze chemical reactions |
| US4963355A (en) * | 1986-06-23 | 1990-10-16 | Igen, Inc. | Production of antibody catalysts |
| US4792446A (en) * | 1986-06-23 | 1988-12-20 | Igen, Inc. | Production of antibody catalysts |
| GB8823869D0 (en) * | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5318897A (en) * | 1989-04-25 | 1994-06-07 | Igen, Inc. | Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| EP1690934A3 (fr) * | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Génération d'anticorps xenogéniques |
| ATE300615T1 (de) * | 1990-08-29 | 2005-08-15 | Genpharm Int | Transgene mäuse fähig zur produktion heterologer antikörper |
| CA2132306C (fr) * | 1992-03-16 | 2012-07-10 | Jacob N. Wohlstadter | Methodes de selection |
| CA2161351C (fr) * | 1993-04-26 | 2010-12-21 | Nils Lonberg | Animaux transgeniques, pouvant produire des anticorps heterologues |
| AU6904794A (en) * | 1993-04-30 | 1994-11-21 | Scripps Research Institute, The | Transgenic animals having an engineered immune response |
| US5919681A (en) * | 1995-06-07 | 1999-07-06 | Wohlstadter Jacob N | Method for promoting enzyme diversity |
| US5914256A (en) * | 1995-06-07 | 1999-06-22 | Wohlstadter Jacob N | Method for promoting enzyme diversity |
-
1996
- 1996-06-06 US US08/671,906 patent/US5922584A/en not_active Expired - Lifetime
- 1996-06-06 JP JP50203197A patent/JP4102435B2/ja not_active Expired - Lifetime
- 1996-06-06 AT AT96919304T patent/ATE274594T1/de active
- 1996-06-06 DE DE69633238T patent/DE69633238T2/de not_active Expired - Lifetime
- 1996-06-06 ES ES96919304T patent/ES2227594T3/es not_active Expired - Lifetime
- 1996-06-06 DK DK96919304T patent/DK0839208T3/da active
- 1996-06-06 EP EP04009086A patent/EP1437414A3/fr not_active Withdrawn
- 1996-06-06 AU AU61674/96A patent/AU719670B2/en not_active Expired
- 1996-06-06 CA CA2223716A patent/CA2223716C/fr not_active Expired - Lifetime
- 1996-06-06 EP EP96919304A patent/EP0839208B1/fr not_active Expired - Lifetime
- 1996-06-06 WO PCT/US1996/009827 patent/WO1996040960A1/fr not_active Ceased
- 1996-06-07 ZA ZA964889A patent/ZA964889B/xx unknown
-
1998
- 1998-12-30 US US09/223,061 patent/US6242236B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0839208A4 (fr) | 2002-05-15 |
| ES2227594T3 (es) | 2005-04-01 |
| DK0839208T3 (da) | 2004-12-13 |
| JP4102435B2 (ja) | 2008-06-18 |
| AU719670B2 (en) | 2000-05-18 |
| EP0839208B1 (fr) | 2004-08-25 |
| JPH11513884A (ja) | 1999-11-30 |
| DE69633238D1 (de) | 2004-09-30 |
| CA2223716C (fr) | 2012-03-13 |
| ATE274594T1 (de) | 2004-09-15 |
| US6242236B1 (en) | 2001-06-05 |
| EP1437414A2 (fr) | 2004-07-14 |
| DE69633238T2 (de) | 2005-09-15 |
| EP0839208A1 (fr) | 1998-05-06 |
| EP1437414A3 (fr) | 2005-01-05 |
| AU6167496A (en) | 1996-12-30 |
| US5922584A (en) | 1999-07-13 |
| CA2223716A1 (fr) | 1996-12-19 |
| WO1996040960A1 (fr) | 1996-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0942959A4 (fr) | Animaux transgeniques non humains capables de produire des anticorps heterologues | |
| DK0854917T3 (da) | Transgene ikke-humane dyr, som kan producere heterologe antistoffer | |
| EP0754225A4 (fr) | Animaux transgeniques capables de produire des anticorps heterologues | |
| EP1354034B8 (fr) | Rongeurs transgeniques et transchromosomiques pour la fabrication d'anticorps humains | |
| EP1069185A4 (fr) | Anticorps humanise contre le facteur tissulaire humain (tf) et procede de production d'anticorps humanises | |
| NO2009012I1 (no) | Humanisert anti-humant IL-6 reseptor monoklonalt antistoff | |
| EP0332424A3 (fr) | Anticorps chimériques, dirigés contre l'antigène humaine carcino-embryonique | |
| IL123649A0 (en) | Regulated genes and uses thereof | |
| AU4417389A (en) | Production of antibodies from transgenic animals | |
| AU2097692A (en) | Method for the production of monoclonal antibodies utilizing a germfree animal | |
| IL97653A0 (en) | Catalytic antibody components | |
| EP0874900A4 (fr) | Acides nucleiques ameliores codant une glycosyltransferase chimere | |
| ZA964889B (en) | A method for promoting enzyme diversity | |
| GB2326643B (en) | Precursors of catalytic antibodies | |
| WO2003013594A3 (fr) | Procede permettant de moduler la formation d'anticorps neutralisants chez les mammiferes et utilisation de ce procede dans la therapie genique, la transgenese animale et l'inactivation fonctionnelle d'une ou plusieurs proteines endogenes | |
| GR3037092T3 (en) | Tyrosinase-activator protein fusion enzyme | |
| WO1996040250A3 (fr) | Immunoglobuline chimerique specifique des plaquettes et procedes d'utilisation | |
| WO1998027200A3 (fr) | Sequences consensus de l'origine de replication d'adn humain et d'adn de mammifere | |
| ATE309371T1 (de) | Protein mit dnase-aktivität | |
| WO1997035015A3 (fr) | Proteine apparentee a la tyrosine-phosphatase | |
| HU9300928D0 (en) | Endothelial-leucocyta adhesion molecule-1 (elam-1) and its antibodies being applicable for treatment of asthma | |
| DE69025761D1 (de) | Verfahren zur erhöhung der rate der modifikation metastabiler bindungen | |
| AU3291697A (en) | Method of inhibiting antigen processing, chimeric proteins reflecting this method, and methods of expressing those proteins | |
| AU3866397A (en) | Microspheres containing immunogens, process for producing the same, and method for immunizing animals with the use of the same | |
| GB9704305D0 (en) | Procollagen assembly |